Related Experiment Video

Updated: Jun 7, 2026

Isolation and Differentiation of Stromal Vascular Cells to Beige/Brite Cells
07:22

Isolation and Differentiation of Stromal Vascular Cells to Beige/Brite Cells

Published on: March 28, 2013

Role of PPAR-gamma in inflammation. Prospects for therapeutic intervention by food components

Harry Martin1

  • 1The New Zealand Institute for Plant & Food Research Limited, Palmerston North 4474, New Zealand. hmartin@hortresearch.co.nz

Mutation Research
|October 26, 2010
PubMed

Insights

Peroxisome proliferator activated receptor gamma (PPARγ) plays a key role in metabolism and immunity. Natural dietary compounds activating PPARγ show promise for managing inflammatory and allergic diseases through diet.

Area of Science:

  • Molecular Biology
  • Immunology
  • Endocrinology

Background:

  • Peroxisome proliferator activated receptor gamma (PPARγ) is a nuclear receptor superfamily member regulating gene expression.
  • PPARγ is known for roles in adipocyte differentiation, fatty acid storage, and glucose metabolism, and is a target for anti-diabetic drugs.
  • Emerging evidence highlights PPARγ's crucial function in immune responses, including inhibiting inflammatory cytokines and promoting anti-inflammatory immune cell phenotypes.

Purpose of the Study:

  • To review the role of PPARγ in immune responses and inflammatory diseases.
  • To explore the potential of natural PPARγ agonists found in foods as anti-inflammatory agents.
  • To discuss the prospects of dietary interventions for inflammatory diseases targeting PPARγ.

Main Methods:

  • Review of existing literature on PPARγ function, ligands, and clinical trial data.
  • Analysis of the structural diversity of PPARγ ligands, including endogenous metabolites, dietary compounds, and synthetic drugs.
  • Evaluation of the therapeutic potential of natural PPARγ agonists in inflammatory and allergic conditions.

Main Results:

  • PPARγ activation by diverse ligands, including dietary constituents, influences immune cell differentiation and inflammatory cytokine production.
  • Natural PPARγ agonists from food sources demonstrate anti-inflammatory properties.
  • Clinical trial results suggest potential benefits of dietary intervention for inflammatory diseases via PPARγ activation.

Conclusions:

  • PPARγ is a significant target for both the pharmaceutical and food industries due to its role in inflammation and metabolism.
  • Dietary intervention strategies targeting PPARγ hold promise for managing inflammatory and allergic diseases.
  • Further research into natural PPARγ agonists could lead to novel therapeutic approaches for inflammatory conditions.

Related Concept Videos

Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...